Successful stem cell transplant with antibody-based conditioning for XIAP deficiency with refractory hemophagocytic lymphohistiocytosis

Blood. 2013 Jun 13;121(24):4966-8. doi: 10.1182/blood-2013-01-478735.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Alemtuzumab
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antineoplastic Agents / administration & dosage*
  • Child, Preschool
  • Genetic Diseases, X-Linked / complications
  • Genetic Diseases, X-Linked / genetics
  • Genetic Diseases, X-Linked / therapy*
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Lymphohistiocytosis, Hemophagocytic / complications
  • Lymphohistiocytosis, Hemophagocytic / genetics
  • Lymphohistiocytosis, Hemophagocytic / therapy*
  • Lymphoproliferative Disorders / complications
  • Lymphoproliferative Disorders / genetics
  • Lymphoproliferative Disorders / therapy*
  • Male
  • Transplantation Conditioning*
  • Transplantation, Homologous
  • Unrelated Donors*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Alemtuzumab

Supplementary concepts

  • Lymphoproliferative Syndrome, X-Linked, 2